Skip to main content
. 2021 Mar 27;276:119376. doi: 10.1016/j.lfs.2021.119376

Fig. 7.

Fig. 7

Heparin/LMWH abrogates the reduced levels of glycocalyx components induced by plasma from COVID-19 patients. Immunofluorescence (40× magnification) of glypican-1 in HUVECs treated with plasma from healthy subjects and COVID-19 patients in the presence of heparin/LMWH or vehicle. Data are representative of at least 3 experiments and are shown as mean ± SEM. One-way ANOVA followed by Tukey post-test. *p < 0.05.